Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

E. Fujimoto · SciRah

Researcher profile · Semantic Scholar

E. Fujimoto

Share profile

E. Fujimoto — researcher profile on SciRah

h-index: 19
Works: 96
Citations: 942

Most-cited papers

AGE-modified collagens I and III induce keratinocyte terminal differentiation through AGE receptor CD36: epidermal-dermal interaction in acquired perforating dermatosis.
E. Fujimoto, Takashi Kobayashi, N. Fujimoto, M. Akiyama +2 more
2010Journal of Investigative Dermatology51 citations Open access
Semantic Scholar
N(ɛ)-(carboxymethyl)lysine modification of elastin alters its biological properties: implications for the accumulation of abnormal elastic fibers in actinic elastosis.
E. Yoshinaga, A. Kawada, K. Ono, E. Fujimoto +4 more
2012Journal of Investigative Dermatology50 citations Open access
Semantic Scholar
Efficacy and safety of baricitinib treatment for moderate to severe atopic dermatitis in real‐world practice in Japan
Teppei Hagino, H. Saeki, E. Fujimoto, N. Kanda
2023Journal of dermatology (Print)46 citations
Semantic Scholar
Leukocytapheresis treatment for pyoderma gangrenosum
E. Fujimoto, N. Fujimoto, K. Kuroda, S. Tajima
2004British Journal of Dermatology37 citations
Semantic Scholar
Effectiveness and safety of deucravacitinib treatment for moderate-to-severe psoriasis in real-world clinical practice in Japan
Teppei Hagino, Hidehisa Saeki, E. Fujimoto, Naoko Kanda
2024Journal of dermatological treatment (Print)35 citations Open access
Semantic Scholar
Effects of Biologic Therapy on Laboratory Indicators of Cardiometabolic Diseases in Patients with Psoriasis
Teppei Hagino, H. Saeki, E. Fujimoto, N. Kanda
2023Journal of Clinical Medicine35 citations Open access
Semantic Scholar
Real‐world effectiveness and safety of bimekizumab in Japanese patients with psoriasis: A single‐center retrospective study
Teppei Hagino, Hidehisa Saeki, E. Fujimoto, Naoko Kanda
2024Journal of dermatology (Print)34 citations Open access
Semantic Scholar
The Eosinophil-to-Lymphocyte Ratio Acts as an Indicator for Improvement of Clinical Signs and Itch by Upadacitinib Treatment in Atopic Dermatitis
Teppei Hagino, H. Saeki, E. Fujimoto, N. Kanda
2023Journal of Clinical Medicine31 citations Open access
Semantic Scholar
Total eosinophil count as a biomarker for therapeutic effects of upadacitinib in atopic dermatitis over 48 weeks
Teppei Hagino, Risa Hamada, Mai Yoshida, E. Fujimoto +2 more
2024Frontiers in Immunology28 citations Open access
Semantic Scholar
The differential effects of upadacitinib treatment on skin rashes of four anatomical sites in patients with atopic dermatitis
Teppei Hagino, H. Saeki, E. Fujimoto, Naoko Kanda
2023Journal of dermatological treatment (Print)28 citations Open access
Semantic Scholar
Effectiveness of switching from baricitinib 4 mg to upadacitinib 30 mg in patients with moderate-to-severe atopic dermatitis: a real-world clinical practice in Japan
Teppei Hagino, Mai Yoshida, Risa Hamada, Hidehisa Saeki +2 more
2023Journal of dermatological treatment (Print)27 citations Open access
Semantic Scholar
Long-term effectiveness and safety of upadacitinib for Japanese patients with moderate-to-severe atopic dermatitis: a real-world clinical study
Teppei Hagino, Hidehisa Saeki, E. Fujimoto, Naoko Kanda
2024Journal of dermatological treatment (Print)26 citations Open access
Semantic Scholar
Effects and cost of glycyrrhizin in the treatment of upper respiratory tract infections in members of the Japanese maritime self-defense force: Preliminary report of a prospective, randomized, double-blind, controlled, parallel-group, alternate-day treatment assignment clinical trial
Y. Yanagawa, M. Ogura, E. Fujimoto, S. Shono +1 more
2004Current Therapeutic Research23 citations Open access
Semantic Scholar
Therapeutic effectiveness of upadacitinib on individual types of rash in Japanese patients with moderate‐to‐severe atopic dermatitis
Teppei Hagino, Mai Yoshida, Risa Hamada, E. Fujimoto +2 more
2023Journal of dermatology (Print)22 citations Open access
Semantic Scholar
Galectin‐7 and actin are components of amyloid deposit of localized cutaneous amyloidosis
Y. Miura, S. Harumiya, K. Ono, E. Fujimoto +5 more
2013Experimental Dermatology22 citations
Semantic Scholar
Effects of Tralokinumab on Clinical and Laboratory Indexes in Atopic Dermatitis: A 24-Week Real-World Study
Teppei Hagino, Marina Onda, Hidehisa Saeki, E. Fujimoto +1 more
2024Dermatitis20 citations
Semantic Scholar
Real-World Effectiveness and Safety of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis: A 16-Week Study in Japan
Teppei Hagino, A. Uchiyama, Marina Onda, K. Kosaka +5 more
2025Dermatitis19 citations
Semantic Scholar
Effectiveness of long‐term bimekizumab treatment and predictive factors for responders in moderate‐to‐severe psoriasis: A 52‐week real‐world study
Teppei Hagino, Hidehisa Saeki, E. Fujimoto, Naoko Kanda
2024Journal of dermatology (Print)19 citations
Semantic Scholar
Effectiveness of bimekizumab for genital, nail, and scalp lesions with psoriasis: A 24‐week real‐world study
Teppei Hagino, Marina Onda, Hidehisa Saeki, E. Fujimoto +1 more
2024Journal of dermatology (Print)19 citations
Semantic Scholar
A 96-week real-world outcome of upadacitinib treatment for atopic dermatitis: systemic therapy-naive versus -experienced patients.
Teppei Hagino, Hidehisa Saeki, E. Fujimoto, Naoko Kanda
2025Journal of American Academy of Dermatology18 citations Open access
Semantic Scholar
Predictive factors for responders to upadacitinib treatment in patients with atopic dermatitis
Teppei Hagino, Mai Yoshida, Risa Hamada, Hidehisa Saeki +2 more
2024Journal of dermatological treatment (Print)17 citations Open access
Semantic Scholar
Long-term effectiveness and safety of deucravacitinib in psoriasis: A 52-week real-world study of genital, scalp, and nail lesions.
Teppei Hagino, Hidehisa Saeki, E. Fujimoto, Naoko Kanda
2024Clincal and Experimental Dermatology17 citations
Semantic Scholar
Reciprocal regulation of LOX and LOXL2 expression during cell adhesion and terminal differentiation in epidermal keratinocytes.
E. Fujimoto, S. Tajima
2009Journal of dermatological science (Amsterdam)17 citations
Semantic Scholar
Effectiveness of deucravacitinib for genital, nail, and scalp lesions with psoriasis: a 24-week real-world study.
Teppei Hagino, Marina Onda, Hidehisa Saeki, E. Fujimoto +1 more
2024Clincal and Experimental Dermatology16 citations
Semantic Scholar
24-Week Real-World Effectiveness and Safety of Lebrikizumab for Atopic Dermatitis in Japan: An Analysis Stratified by Prior Systemic Therapy
Teppei Hagino, A. Uchiyama, Marina Onda, K. Kosaka +5 more
2025Dermatitis14 citations
Semantic Scholar
Identification of Early and Late Responders to Anti-IL-13 Antibody Tralokinumab in Atopic Dermatitis: A Real-World Japanese Study
Teppei Hagino, Hidehisa Saeki, E. Fujimoto, Naoko Kanda
2024Dermatitis14 citations
Semantic Scholar
In Vitro Amyloidogenic Peptides of Galectin-7
K. Ono, E. Fujimoto, N. Fujimoto, M. Akiyama +4 more
2014Journal of Biological Chemistry14 citations Open access
Semantic Scholar
Effectiveness and Safety of Upadacitinib in Combination with Topical Corticosteroids in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis
Teppei Hagino, Risa Hamada, Mai Yoshida, E. Fujimoto +2 more
2023Clinical, Cosmetic and Investigational Dermatology13 citations Open access
Semantic Scholar
Background factors predicting the occurrence of herpes zoster in atopic dermatitis patients treated with upadacitinib
Teppei Hagino, H. Saeki, E. Fujimoto, Naoko Kanda
2023Journal of dermatology (Print)13 citations
Semantic Scholar
Effectiveness of Dose Increase in Upadacitinib from 15 mg to 30 mg for Patients with Moderate-to-Severe Atopic Dermatitis: A Real-World Clinical Practice in Japan
Teppei Hagino, Risa Hamada, Mai Yoshida, Hidehisa Saeki +2 more
2024Clinical drug investigation12 citations
Semantic Scholar
Real‐world experience of switching from tralokinumab to lebrikizumab in atopic dermatitis
Teppei Hagino, A. Uchiyama, K. Kosaka, Takeshi Araki +4 more
2025Journal of the European Academy of Dermatology and Venereology11 citations
Semantic Scholar
Predictive Factors for Long-Term High Responders to Upadacitinib Treatment in Patients with Atopic Dermatitis
Teppei Hagino, Hidehisa Saeki, E. Fujimoto, Naoko Kanda
2024Dermatitis11 citations
Semantic Scholar
Effectiveness and safety of tralokinumab treatment for moderate-to-severe atopic dermatitis in real-world clinical practice in Japan.
Teppei Hagino, Marina Onda, Hidehisa Saeki, E. Fujimoto +1 more
2024EJD. European journal of dermatology11 citations
Semantic Scholar
Early itch relief with upadacitinib predicts later skin clearance in Atopic dermatitis
Teppei Hagino, Mai Yoshida, Risa Hamada, Hidehisa Saeki +2 more
2023Journal of dermatological treatment (Print)10 citations Open access
Semantic Scholar
A 48-week real-world outcome of tralokinumab treatment for atopic dermatitis: Systemic therapy-naïve versus -experienced patients.
Teppei Hagino, A. Uchiyama, K. Kosaka, Takeshi Araki +4 more
2025Journal of American Academy of Dermatology9 citations
Semantic Scholar
Effectiveness of Tralokinumab for Different Anatomical Sites and Clinical Signs in Atopic Dermatitis: A 36-Week Real-World Study
Teppei Hagino, Hidehisa Saeki, E. Fujimoto, Naoko Kanda
2025Dermatitis9 citations
Semantic Scholar
Sustained Effectiveness of Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A 48-Week Real-World Study
Teppei Hagino, Risa Hamada, Mai Yoshida, Hidehisa Saeki +2 more
2024Pharmaceuticals9 citations Open access
Semantic Scholar
Predictive Factors for Poor Responders to Tralokinumab in Moderate-to-Severe Atopic Dermatitis: A Real-World Analysis
Teppei Hagino, Hidehisa Saeki, E. Fujimoto, Naoko Kanda
2025Dermatitis8 citations
Semantic Scholar
Long‐term real‐world effectiveness of deucravacitinib in psoriasis: A 52‐week prospective study stratified by prior apremilast or biologic therapy
Teppei Hagino, Hidehisa Saeki, E. Fujimoto, Naoko Kanda
2025Journal of dermatology (Print)8 citations Open access
Semantic Scholar
Real‐world 52‐week effectiveness of deucravacitinib in psoriasis: A stratified analysis by age and body mass index
Teppei Hagino, Marina Onda, Hidehisa Saeki, E. Fujimoto +1 more
2025Journal of dermatology (Print)7 citations
Semantic Scholar
Letter: Real-World Japanese Study of the Effectiveness and Safety of Switching From Dupilumab to Lebrikizumab in Patients with Moderate to Severe Atopic Dermatitis
Teppei Hagino, A. Uchiyama, Marina Onda, K. Kosaka +5 more
2025Dermatitis7 citations
Semantic Scholar
Effectiveness of Switching From Upadacitinib to Tralokinumab in Patients With Moderate-to-Severe Atopic Dermatitis: A Real-World Clinical Practice
Teppei Hagino, Hidehisa Saeki, E. Fujimoto, Naoko Kanda
2025Annals of Dermatology6 citations
Semantic Scholar
Thirty-Six-Week Real-World Effectiveness of Lebrikizumab for Different Anatomical Sites and Clinical Signs in Atopic Dermatitis: Results from a Prospective Japanese Study.
Teppei Hagino, A. Uchiyama, K. Kosaka, Takeshi Araki +4 more
2025Dermatitis6 citations
Semantic Scholar
Predictive Factors for Primary and Secondary Nonresponders to Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis: A Real-World Study
Teppei Hagino, Hidehisa Saeki, E. Fujimoto, Naoko Kanda
2024Dermatitis6 citations
Semantic Scholar
Predictive factors for responders to deucravacitinib treatment in patients with psoriasis
Teppei Hagino, Marina Onda, Hidehisa Saeki, E. Fujimoto +1 more
2024Journal of dermatology (Print)6 citations
Semantic Scholar
Bimekizumab for the treatment of genital, scalp, and nail psoriasis: A 52‐week real‐world study
Teppei Hagino, Hidehisa Saeki, E. Fujimoto, Naoko Kanda
2024Journal of dermatology (Print)5 citations
Semantic Scholar
Ultraviolet irradiation may generate plane xanthomas on mycosis fungoides
N. Fujimoto, H. Mieno, R. Hosokawa, E. Fujimoto +1 more
2013British Journal of Dermatology5 citations
Semantic Scholar
Long‐Term, Site‐Specific Effectiveness of Tralokinumab in Atopic Dermatitis: A 72‐Week Real‐World Study
Mizuki Shiba, Teppei Hagino, A. Uchiyama, Hidehisa Saeki +3 more
2026Journal of dermatology (Print)4 citations Open access
Semantic Scholar
The Sustainability of Week 16 Responses to Deucravacitinib Treatment for Patients With Psoriasis
Mizuki Shiba, Teppei Hagino, Hidehisa Saeki, E. Fujimoto +1 more
2025Journal of dermatology (Print)4 citations
Semantic Scholar
Transition of Blood Biomarkers During 24-Week Treatment With Lebrikizumab or Tralokinumab in Atopic Dermatitis: A Real-World Analysis Stratified by Prior Systemic Therapy.
Teppei Hagino, A. Uchiyama, K. Kosaka, Takeshi Araki +4 more
2025Dermatitis4 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Teppei Hagino×42
Invite
Teppei Hagino — researcher profile on SciRah
Naoko Kanda×39
Invite
Naoko Kanda — researcher profile on SciRah
Hidehisa Saeki×35
Invite
Hidehisa Saeki — researcher profile on SciRah
Marina Onda×9
Invite
Marina Onda — researcher profile on SciRah

Invite

Risa Hamada — researcher profile on SciRah

Invite

Mai Yoshida — researcher profile on SciRah

Invite

A. Uchiyama — researcher profile on SciRah

Invite

S. Motegi — researcher profile on SciRah

Invite

H. Saeki — researcher profile on SciRah

Invite

K. Kosaka — researcher profile on SciRah

Takeshi Araki×7

Invite

Takeshi Araki — researcher profile on SciRah

Invite

S. Tajima — researcher profile on SciRah